USNA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
USANA Health Sciences Inc (USNA) is not a good buy for a beginner investor with a long-term strategy at this time. The financial performance is weak, with declining net income and EPS, and there are no strong positive catalysts or trading signals to support immediate investment. Additionally, the stock shows a higher probability of short-term decline based on historical patterns.
The MACD is positive but contracting, RSI is neutral at 53.215, and moving averages are converging, indicating no clear trend. Key support is at 18.042, and resistance is at 20.502. Overall, the technical indicators suggest a neutral stance.
NULL identified. No recent news, no significant hedge fund or insider activity, and no recent congress trading data.
Weak financial performance in 2025/Q4 with a net income drop of -139.85% YoY and EPS decline of -143.48% YoY. Gross margin also decreased by -4.62% YoY. Historical stock trend analysis indicates a higher probability of short-term decline (-8.8% in the next day, -9.43% in the next week, -11.09% in the next month).
In 2025/Q4, revenue increased by 5.89% YoY to $226.2M, but net income dropped to -$1.775M (-139.85% YoY), EPS fell to -$0.1 (-143.48% YoY), and gross margin declined to 78.16% (-4.62% YoY).
No analyst rating or price target data provided.
